Morgan Dempsey Capital Management LLC Has $5.34 Million Holdings in Johnson & Johnson (JNJ)

Morgan Dempsey Capital Management LLC boosted its position in Johnson & Johnson (NYSE:JNJ) by 5.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,396 shares of the company’s stock after buying an additional 1,972 shares during the period. Johnson & Johnson makes up 1.9% of Morgan Dempsey Capital Management LLC’s holdings, making the stock its 14th biggest holding. Morgan Dempsey Capital Management LLC’s holdings in Johnson & Johnson were worth $5,343,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of JNJ. Lenox Wealth Advisors Inc. boosted its stake in Johnson & Johnson by 0.6% in the second quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after acquiring an additional 5 shares during the last quarter. Lbmc Investment Advisors LLC lifted its stake in shares of Johnson & Johnson by 0.4% during the 1st quarter. Lbmc Investment Advisors LLC now owns 3,704 shares of the company’s stock valued at $461,000 after buying an additional 14 shares in the last quarter. Stratford Consulting LLC lifted its stake in shares of Johnson & Johnson by 0.6% during the 2nd quarter. Stratford Consulting LLC now owns 2,728 shares of the company’s stock valued at $361,000 after buying an additional 16 shares in the last quarter. Iron Financial LLC lifted its stake in shares of Johnson & Johnson by 0.5% during the 2nd quarter. Iron Financial LLC now owns 3,782 shares of the company’s stock valued at $500,000 after buying an additional 19 shares in the last quarter. Finally, North Point Portfolio Managers Corp OH lifted its stake in shares of Johnson & Johnson by 0.7% during the 2nd quarter. North Point Portfolio Managers Corp OH now owns 2,923 shares of the company’s stock valued at $387,000 after buying an additional 20 shares in the last quarter. 65.90% of the stock is owned by hedge funds and other institutional investors.

Johnson & Johnson (NYSE:JNJ) traded up $1.39 during mid-day trading on Wednesday, hitting $141.06. 5,591,327 shares of the company traded hands, compared to its average volume of 5,875,277. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32. Johnson & Johnson has a 52 week low of $109.32 and a 52 week high of $144.35. The company has a market cap of $377,720.00, a price-to-earnings ratio of 19.47, a P/E/G ratio of 2.83 and a beta of 0.80.

Johnson & Johnson (NYSE:JNJ) last released its earnings results on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.80 by $0.10. The company had revenue of $19.65 billion for the quarter, compared to analyst estimates of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.68 EPS. equities analysts predict that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Tuesday, November 28th will be given a $0.84 dividend. The ex-dividend date is Monday, November 27th. This represents a $3.36 annualized dividend and a dividend yield of 2.38%. Johnson & Johnson’s dividend payout ratio is 58.33%.

A number of brokerages recently commented on JNJ. J P Morgan Chase & Co upped their price target on shares of Johnson & Johnson from $140.00 to $148.00 and gave the company an “overweight” rating in a research note on Wednesday, August 16th. Citigroup began coverage on shares of Johnson & Johnson in a research note on Monday, September 25th. They issued a “neutral” rating and a $140.00 target price on the stock. Jefferies Group set a $145.00 target price on shares of Johnson & Johnson and gave the stock a “hold” rating in a research note on Tuesday, August 15th. BMO Capital Markets reiterated a “positive” rating and issued a $152.00 target price (up from $145.00) on shares of Johnson & Johnson in a research note on Wednesday, October 18th. Finally, Royal Bank Of Canada increased their target price on shares of Johnson & Johnson from $144.00 to $147.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $144.59.

TRADEMARK VIOLATION NOTICE: “Morgan Dempsey Capital Management LLC Has $5.34 Million Holdings in Johnson & Johnson (JNJ)” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://stocknewstimes.com/2017/12/06/morgan-dempsey-capital-management-llc-grows-stake-in-johnson-johnson-jnj.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply